p65 Homodimer activity in distal airway cells determines lung dysfunction in equine heaves.

This research examines the role of the molecule NF-kappaB in the lung disease “heaves” in horses, noting that its increased activity in various lung cells and direct correlation to lung resistance suggest it plays a crucial role in this disease.

Overview of the Study

• This study primarily aimed to understand if increased Nuclear factor-kappaB (NF-kappaB) activity, which is vital in regulating inflammatory gene expression, can be associated with a disease known as ‘heaves’ that affects horse’s lungs.
• Heaves, technically known as Recurrent Airway Obstruction (RAO), is an inflammatory condition in horses that can lead to severe respiratory distress.
• The researchers identified that NF-kappaB activity was heightened in cells collected from broncho-alveolar lavage (BAL) in horses affected by heaves, particularly during disease exacerbation.

Findings of the Study

• The research discovered a significant increase in NF-kappaB activity in cells from horses suffering from heaves, primarily during the disease crisis, compared to healthy horses.
• NF-kappaB activity level in BAL cells was found to have positive correlation with total lung resistance, an indicator of impaired respiratory function, and proportion of neutrophils, a type of immune cell often linked with inflammation, present in BAL fluid.
• The study distinctly found prototypical p65-p50 NF-kappaB heterodimers, two interconnected proteins playing a role in cell inflammation, were absent, and instead, p65 homodimers were mainly present in the BAL cells. This suggests the presence of p65 homodimers plays an important role in neutrophilic inflammation, a type of inflammation marked by a strong presence of neutrophils.

Implications and Conclusion

• This research concludes that elevated NF-kappaB activity is a typical characteristic of ‘heaves’ within the lungs.
• The findings highlight the significance of p65 homodimers in the inflammation process associated with heaves.
• It suggests NF-kappaB inhibitors might prove to be helpful and improve lung function in horses with heaves. This can lead to new therapeutic strategies to manage this often chronic and debilitating condition in horses.